Weill Cornell Medicine announced April 28 a gift made by WorldQuant LLC and Igor Tulchinsky that will further realize the promise of precision medicine.
Latest news from The Englander Institute for Precision Medicine:
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave the way for new targeted treatment approaches.
Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct an in-depth study of the molecular machinery driving the most aggressive form of prostate cancer.
Bishoy Faltas, MBBCh, Instructor in Medicine at Weill Cornell Medicine, was named a NextGen Star of the American Association for Cancer Research (AACR), an award that supporting the development and professional advancement of early-career scientists in cancer research. Dr.